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Background: This study aims for health gain and cost reduction in the care for people with long-term non-psychotic
psychiatric disorders. Present care for this population has a limited evidence base, is often open ended, little effective,
and expensive. Recent epidemiological data shows that 43.5% of the Dutch are affected by mental illness during
their life. About 80% of all patients receiving mental health services (MHS) have one or more non-psychotic disorders.
Particularly for this group, long-term treatment and care is poorly developed. Care As Usual (CAU) currently is a form
of low-structured treatment/care. Interpersonal Community Psychiatric Treatment (ICPT) is a structured treatment for
people with long-term, non-psychotic disorders, developed together with patients, professionals, and experts. ICPT uses
a number of evidence-based techniques and was positively evaluated in a controlled pilot study.
Methods/Design: Multi-centre cluster-randomized clinical trial: 36 professionals will be randomly allocated to either
ICPT or CAU for an intervention period of 12 months, and a follow-up of 6 months. 180 Patients between 18–65 years
of age will be included, who have been diagnosed with a non-psychotic psychiatric disorder (depressive, anxiety,
personality or substance abuse disorder), have long-term (>2 years) or high care use (>1 outpatient contact per
week or >2 crisis contacts per year or >1 inpatient admission per year), and who receive treatment in a specialized
mental health care setting. The primary outcome variable is quality of life; secondary outcomes are costs, recovery,
general mental health, therapeutic alliance, professional-perceived difficulty of patient, care needs and social contacts.
Discussion: No RCT, nor cost-effectiveness study, has been conducted on ICPT so far. The empirical base for current
CAU is weak, if not absent. This study will fill this void, and generate data needed to improve daily mental health care.
Trial registration: Netherlands Trial Register (NTR): 3988. Registered 13th of May 2013.
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In the Netherlands, as in many other developed coun-
tries, many people suffer from psychiatric disorders dur-
ing their life. Recent epidemiological data show that
43.5% of the Dutch are affected by some form of mental
illness during their life [1]. Depression (20.1%), anxiety
(19.6%), and substance abuse (19.1%) have the highest
lifetime prevalence: the first two appear in the Dutch
top-4 of diseases with the highest disease burden [2].
Comorbidity with personality disorders, which have a
prevalence of 9.1% in western society [3], results in
poorer social functioning and limited recovery.
About 80% of all patients receiving mental health ser-
vices (MHS) have one or more of the aforementioned
non-psychotic disorders [4]. Between 16-18% of these
patients do not respond well to short-term treatment
(i.e. <15 contacts or <1 year treatment) and end up in
long-term care [5,6]. Long-term treatment and care are
poorly developed: 50-70% of these patients receive a
form of long-term supportive treatment/counselling/
care, which we refer to as care as usual (CAU). CAU
currently is a low-structured treatment/care: biweekly
contacts with a nurse, social worker or occupational
therapist, in which daily issues are discussed [7]. The
other 30-50% of the patients receive long-term psycho-
therapy – of which many are eventually referred to long-
term CAU. Thus, often when short-term treatment has
proven ineffective, long-term care with a poor focus is
the only alternative. Specific treatments for subgroups,
e.g. patients with chronic depression, exist [8] but are
not widely implemented. As a result, large numbers of
people yearly receive a non-descript form of long-term
care. The lack of direction in CAU results in: 1) very
long-term care (e.g. up to 10 years [9]) and 2) high care
use. Several studies show that 10-30% of chronic pa-
tients use 50-80% of mental health care’s resources [10].
These resources include (intensive) ambulatory care, as
well as services such as crisis intervention outside office
hours, ambulance transport, and admissions to hospitals,
and ER/ casualty-departments. Long-term and intensive
care use is highly correlated with the perceived patient
‘difficulty’ [11,12]. When a patient is labeled ‘difficult’
quality of care often becomes low [13]. For patients this
results in lower quality of life, more symptoms, and even
higher care use [14].
For those patients who receive CAU, we developed
Interpersonal Community Psychiatric Treatment (ICPT).
Feasibility and preliminary effectiveness of ICPT were
evaluated in a controlled pilot-study [9], in which ICPT
was more successful than CAU on a number of outcome
variables. Patients gained quality of life and social con-
tacts, and used fewer health care services. Professionals
(e.g. community psychiatric nurses and nurse specialists)
valued the therapeutic alliance more positively, andexperienced both patients and patient care as less ‘diffi-
cult’. ICPT is not yet standard care but is being used on
a small scale. Given the positive outcomes in a group of
patients with complex needs, ICPT seems a promising
intervention. Yet data from RCTs on the (cost) effective-
ness of ICPT is not available.
Target population
The intervention in this study aims at a broad group of
patients in terms of psychiatric diagnosis (non-psychotic
disorders in several combinations) and in terms of demo-
graphic characteristics (although women, and persons
with a lower socio-economic status are overrepresented),
but a specific group in terms of care use (long-term and
intensive). The severity of the disorder may account for
the long duration of care, yet in psychiatric care people
may also become accustomed to using services. Some
studies highlight such iatrogenic dependency [15], and
show very high service use of non-psychotic patients
across health and social services [10]. We specifically
aim at this group of patients, who have serious mental
illnesses, but who may also have become accustomed to
long term or high care use. These patients may be per-
ceived as ‘difficult’ [16] and difficult-to-place, and be
passed around by services [11]. They may get lost in the
system, since they neither fit in long-term care pro-
grams (mostly aimed at patients with psychotic disor-
ders), nor in short-term therapy (mostly aimed at
patients with singular non-psychotic disorders, who
respond well to medication and/or psychotherapy). In-
stead of keeping on ‘pampering and dithering’ we offer
this group a generic program that aims at improving
quality of life while decreasing costs.
Research aim and hypotheses
This study aims at comparing the effectiveness and costs
of ICPT in the treatment of people with long-term non-
psychotic mental illness to CAU.
Based on a previous controlled pilot study of 36
patients [9], our main hypothesis is that ICPT is more
effective in improving patients’ quality of life and social
networks than CAU. Further, we hypothesize that ICPT
is more effective in preventing or decreasing profes-
sionals’ perception of patients as ‘difficult’ , resulting in
higher quality of care than CAU and that ICPT is more
effective in discharging patients to a lower level of care
(i.e. general mental health care instead of specialized
mental health care) and more cost-effective in reaching
aforementioned clinical goals than CAU.
Methods/Design
Design
Multi-centre cluster-randomized clinical trial: participat-
ing professionals will be randomly allocated to either ICPT
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a follow-up of 6 months (total 18 months). Participating
patients will receive ICPT or CAU during 12 months.
There is a measurement at baseline, an intermediate
measurement (6 months after baseline), after the inter-
vention period (12 months after baseline), and a follow-
up measurement (6 months after end of intervention,
18 months after baseline).
Randomization
The professionals (clusters) will be randomized the inter-
vention (ICPT) or the control group (CAU) using ran-
domized stratification by an independent statistician. The
allocation sequences will be generated with an automatedFigure 1 Participant Flow Chart.algorithm by a statistician independent from the recruiter
of the professionals using a random sequence generation.
Inclusion and exclusion criteria
Patients between 18–65 years of age with a presence of a
non-psychotic psychiatric disorder such as depressive,
anxiety and/or personality disorder and/or substance
abuse and long-term treatment (>2 years) or high care
use (>1 outpatient contact per week or >2 crisis contacts
per year or >1 inpatient admission per year) in secondary
mental health services will be included. Patients with a
psychotic, bipolar I or cognitive disorder (e.g. dementia)
and a lack of skill in understanding of, or communication
in Dutch language are excluded.
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patients with a non-psychotic disorder, who are willing
to be randomized to either CAU or the experimental
ICPT-condition and have not expressed intention to
leave the present service between now and 12 months
are included. Refer to Figure 1 Participant flowchart for
details.
Sample size calculation
This study’s sample size calculation is based on the pri-
mary outcome variable, quality of life as measured with
the Manchester Short Assessment of Quality of Life
(MANSA), for which we found an effect size of 0.3 in
our pilot study [17]. In a patient group in which quality
of life is difficult to improve, an effect size of 0.3 signifies
clinically meaningful progress. Furthermore we assumed
a conservative Intra Cluster Correlation of 0.10 for
clustering of patients, based on the scarce literature on
the correlation between long-term psychiatric patients
within one professional [17]. The correlation between
baseline and follow-up measurement, also from our pilot
study, was set at 0.5 and 0.8 for cluster and subject level,
respectively. With an alpha of 0.05, and a power of 0.80,
36 clusters (professionals) of 5 participants (patients)
each are required (total of 36 professionals and 180 pa-
tients needed for the analysis).
Ethics
A certified Medical Ethics Review Committee, The
Clinical Research Centre Nijmegen (CRCN), in The
Netherlands has approved this study, registered under
NL44744.091.13. This ethical approval covers all sites
of data collection.
Procedure
Three large mental health institutions participate in this
study. Within these departments, professionals will be
asked to participate in this study, and be randomized to
either ICPT or CAU. Once a professional is included in
the study, his or her patients meeting the inclusion cri-
teria at patient level, will be informed about the study
and be invited to participate. This invitation letter (to
which a brochure about the research is attached), will be
signed by the professional, and sent by the department’s
management. Patients who express their willingness to
participate may either contact their professional or the
research team directly. The research team will then con-
tact them by telephone or email, make an appointment
for a face-to-face contact, and send formal information
about participating in the study by post. In this face-to-
face meeting the researcher will explain the study
verbally, and obtain informed consent if the patient is
indeed willing to participate.Treatment integrity
Treatment integrity in the experimental condition will
be monitored and discussed by means of supervision.
Since there is no clear treatment guideline for CAU,
treatment integrity will not be monitored in the control
group. Randomly selected audiotapes of treatment ses-
sions will be evaluated by independent raters (Master-
level students familiar with ICPT) masked to treatment
condition. They will assess whether the tape is CAU or
ICPT, and to which extent ICPT-elements are indeed
used. The ICPT-professionals assess the ICPT-form and
the attached scoring form after each session [9].
Treatments
ICPT
Apart from various specific methods, the focus of ICPT
very much lies on the participation of patients through
attention for the interaction between patient, profes-
sional and social system. The match between patient and
professional is highly important for the future course of
the care process [17]. In ICPT, the patient is strongly en-
couraged to take responsibility for his or her recovery.
Likewise, in the ICPT-training the professional is taught
not to present him or herself as the all-knowing expert,
but rather as a facilitator – yet within a clear frame and
structure.
A number of stages were conceptualized in the inter-
vention program, each fitting an important step in the
theoretical model, resulting in three stages that fit the
patient’s level of acceptance of help and cooperation.
Apart from these stages (described in detail below), we
concluded that an intervention for this patient group
program should focus on: (1) a clear generic treatment
structure (to prevent uninformed and haphazard
low-dosage help), (2) a phased model (which fits the
patient’s level of acceptance of help), (3) a therapeutic
style that fits the phase the patient is in, (4) a routine
monitoring of the interpersonal contact between pa-
tient and professional, and (5) support for team profes-
sionals [18].
I. Generic structure: Based on various evidence-based
treatments of specific non-psychotic disorders
[19,20], we introduced a fixed structure for each
session, taking 45 minutes as the standard duration.
The first 5 minutes are used by the professional and
the patient to set a mutually agreed on agenda for
the session. The next 5 minutes are used to look
back from the current to the previous session. In the
following 25–30 minutes the themes set on the
agenda, are discussed and summarized. The last
5 minutes are used to look back on the session and
to fill out a report form (professional) and a feedback
form (patient).
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from the 1st stage (optimization of working alliance),
through the 2nd stage (clarification of an agreement
on goals and tasks) to the 3rd stage (improvement
of psychiatric and social functioning). In order to
optimize the patient-professional interaction across
all stages, it is crucial for the professional to determine
in which stage the treatment contact is located. The
stage model helps professionals to structure their
treatment, using different methods across different
stages.
III. Therapeutic methods per stage: One of the crucial
elements of ICPT, in order to prevent ineffective
illness behaviour and professional behaviour, is the
differentiation of therapeutic styles across treatment
stages. This approach is a variation of, but consistent
with, the trans-theoretical model of change [21]
which differentiates people’s readiness to change into
various stages. Different methods (e.g. motivational
interviewing) are used to prevent the usual mental
health treatment ‘script’. In this script, the professional
is the one who looks for problems in the patient and
suggests improvements of his or her behaviour, while
the patient is a passive recipient of help. In the second
stage of ICPT, motivational interviewing is used to do
enable systematic goal-setting. After an initial open
question to focus the patient on the future, a widely
used tool to assess care needs [22] is used, after which
specific goals are jointly formulated. This careful
process of mutual goal setting seeks to avoid common
pitfalls: the patient feeling that treatment goals are
forced upon him or her, and the professional feeling
that urgent patient needs (e.g. financial problems)
have not come under discussion. In the third stage of
ICPT, three different goal-oriented methods are used
to improve personal and social functioning. Practical
case management, motivational interviewing and
aspects of cognitive behaviour therapy may be used.
This third stage of ICPT, which may not be reached
by all patients, aims to offer practical help after
goal-setting in stage two has been concluded.
IV. Application of feedback forms: In ICPT, both
professional and patient fill out a form about the
session they have just had. Both rate items on the
Session Rating Scale [23], thereby informing one
another on their (dis) content with the working
alliance. In addition, professionals score in which
stage of the treatment contact this session could be
located, as well as which methods were used, if
treatment goals were discussed, and a number of
other elements, using the ICPT-form and scoring
form after each session [9]. Patients, on the other
hand, rate their own input in the session’s content.
By these means, both parties are delegatedresponsibility for the working alliance and their
substantive input in the session.
V. Supervision: Every two weeks, a team-wise
supervision takes place in which a treatment
situation of two different professionals is jointly
analysed. We use a brief version of a supervision
protocol that has been developed and evaluated in
Dutch long-term mental health care [24].CAU
Care as usual (CAU) currently is a low-structured treat-
ment/care: biweekly contacts with a nurse, social worker
or occupational therapist, in which daily issues are dis-
cussed [7]. This CAU lacks an empirical and theoretical
base and may foster dependence and repeated crises
through its ad-hoc character [25] and lack of clear aims
[26]. Without a clear frame, this CAU turns into – polit-
ically incorrect – ‘pampering and dithering , reinforcing
patients’ dependency and high care use [27]. The present
CAU is offered by non-academically trained profes-
sionals (e.g. nurses and social workers) who have always
relied on practical, day-to-day interventions in acute cir-
cumstances (e.g. locked units or psychosocial crises).
Although these generalizing statements do not apply
to all of these professionals, most – if not all – of them
feel that they lack a solid theoretical base from which to
understand the disorder, its long (er) term character, and
possible treatment.
Participating professionals in the experimental condi-
tion will receive a 4-day training in ICPT over 4 weeks’
time. The ICPT-training has been piloted twice before,
and consists of the following elements: (1) theoretical
overview (4 hours), (2) generic ICPT-skills, e.g. agenda
setting (4 hours), (3) relationship management skills
(8 hours), (3) motivational interviewing and goal setting
skills (8 hours), (4) case-management skills and behav-
ioural analysis skills (4 hours) and skills to discharge pa-
tients to a lower form of care. It combines lectures,
group discussions, one-on-one and group-wise role-
playing, homework assignments, and self-study of pro-
vided literature. Substantial effort is put in tailoring the
training program to the needs and competencies of the
participants. Some of the ICPT-methods for patients
with non-psychotic disorders are aimed at Master-level
professionals (e.g. Cognitive Behavioural Therapy), whereas
the participating professionals – the key professionals of
patients and also those intended to carry out ICPT –
usually have Bachelor-level qualifications. Tailoring will
be done by inviting specialists with extensive experience
with both the target group of professionals, and the
method to be taught. In following group-wise supervi-
sion sessions ICPT-skills will be practiced, and cases
will be discussed.
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Demographic variables
At baseline, participants complete questions concerning
living situation, marital status, education, income and
working situation.
Baseline
Table 1 schematically shows the instruments used in the
study. A structured diagnostic interview about the pa-
tient’s diagnosis is the first step in the baseline assessment.
Axis I psychiatric disorders will be assessed by use of
the electronic version of the MINI Plus (Mini Neuro-
psychiatric Interview) [28]. The MINI Plus is the briefest
full psychiatric interview available and takes, dependent
on the number of disorders, between 15 and 45 minutes.
A 10-item screening instrument will be used to assess
whether a full structured diagnostic interview for Axis II
psychiatric disorders is required. The Standardised Assess-
ment of Personality – Abbreviated Scale - Self Report
(SAPAS-SR) has been found one of the briefest, most
sensitive and specific screening instruments for Axis II
disorders [29]. We expect about 50% positive screens in
this secondary care sample. A positive screen will be
followed by the Structured Interview for DSM-IV
(SIDP-IV) [30]. The SIDP-IV is a widely used semi-
structured interview with good psychometric properties.Table 1 Measuring instruments
Instrument Measuring moments
T0(baseline) T
Filled in by researcher
Demographic questionnaire X X
MINI Plus X
SAPAS-SR X
SIDP-IV (when SAPAS-SR positive) X
CANSAS (Patient) X X
SNM X X
Filled in by patient
OQ-45.2 X X
MANSA X X
IMR (Patient) X X
EQ-5D X X
TiC-P X X
STAR (Patient) X X
Filled in by professional
DDPRQ X X
HONOS X X
CANSAS (Professional) X X
IMR (professional) X X
STAR (professional) X XAll outcome measures (MANSA; HONOS; IMR; EQ-
5D; OQ45; TiC-P; STAR; DDPRQ; CANSAS; SNM) will
be assessed at baseline, and at 6 months, 12 months and
18 months. Referral to lower intensive services will be
assessed at the 12-month and 18-month measurement.
Primary outcome
Quality of life
Quality of life is measured on participant level with the
MANSA [31]. The MANSA (Manchester Short Assess-
ment of Quality of Life) is the single most used quality
of life instrument for patients with severe mental illness.
It is a 16-item patient-rated instrument with good psy-
chometric properties.
Secondary outcomes
Quality of life
The EQ-5D (EuroQol 5D) [32] is a patient-rated meas-
urement of health-related quality of life, providing a gen-
eric measure of health for clinical and economic appraisal.
It is applicable to a wide range of health conditions and
treatments, and provides a single index value for health
status that can be used in the clinical and economic evalu-
ation of health care. It is a 5-item patient-rated instrument
with good psychometric properties that allows the calcula-
tion of QALY’s and DALY’s.1(6 months) T2(12 months) T3(18 months)
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
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The HONOS (Health of the Nation Outcome Scale) is a
12-item professional-rated instrument to assess general
mental health in predominantly SMI-patients [33] with
good psychometric properties and a mean duration of
10 minutes [34].
Treatment
The OQ-45 (Outcome Questionnaire) a 45-item instru-
ment which assesses treatment outcome, mostly in terms
of symptom reduction [35] with very good psychometric
properties and a mean duration of 10 minutes [36].
Recovery
The Illness Management and Recovery (IMR) [37] scale
was created to measure recovery outcomes produced by
the IMR program. However, many other mental health
care programs are now designed to impact recovery-
oriented outcomes, and the IMR has been identified as a
potentially valuable measure of recovery-oriented mental
health outcomes in general. Psychometric properties
were moderate and the scale has a mean duration of
10 minutes.
Costs
The Tic-P (Trimbos/iMTA questionnaire for Costs asso-
ciated with Psychiatric Illness) [38] measures direct costs
of medical treatments such as the number of contacts
with psychiatric services, the GP and multiple other care
providers, psychometric properties are unknown and has
a mean duration of 10 minutes.
Referral to lower intensive services/primary care
Through administrative records it will be assessed to
which extent patients are referred to lower intensive
services, most likely primary care.
Therapeutic relationship
The STAR (Scale To Assess the Therapeutic Relation-
ship) [39] is a 12-item instrument that measures the
quality of the therapeutic alliance between patients with
severe mental illness and professionals. It is adminis-
tered both by patients (STAR-P) and professionals
(STAR-C), and has good psychometric properties.
The DDPRQ (Difficult Doctor Patient Relation Ques-
tionnaire) [40] is a 10-item instrument that assesses prob-
lems in the relationship between patient and professional
and the perceived difficulty with very good psychometric
properties.
Care needs
The CANSAS (Camberwell Assessment of Need Short
Appraisal Schedule) [22] is the single most used care
needs assessment instrument among people with severemental illness. Both the patient’s perception (through an
interview by the researcher), and the professional’s percep-
tion (self-rated) are assessed through a 22-item checklist
that measures met, unmet, and total needs for care.
Social network
The Social Network Map (SNM) [41] is a researcher-
assessed instrument using both a graphical (map) and
textual (grid) instrument to assess the patient-perceived
quantity and quality of his or her social network. The
map is divided into sectors (household, other family,
work/school, formal services, friends, neighbours, and
clubs/organizations/church). The psychometric qualities
of the instrument, as in all social network instruments,
are acceptable.
Statistical analyses
The primary outcome will be analysed using a linear
mixed model (multilevel) to account for the nesting of
clients within professionals and for the correlation over
time of repeated measurements within subjects. The
effect of ICPT versus CAU will be adjusted for important
client and professional characteristics (e.g. quality of life)
by including the latter as fixed effects in the model.
Similar mixed models will be used to analyse the
continuous secondary outcomes. All analyses will be
performed on an intention-to-treat basis.
Health economic evaluation
This study will investigate the potential efficiency of
Interpersonal Community Psychiatric Treatment (ICPT)
versus current long-term care (CAU) from a societal
perspective. The economic evaluation will be based on
the general principles of a cost-effectiveness analysis as
described by Drummond et al. [42] and will be per-
formed along-side the (cluster randomized) clinical trial.
Outcome measures for the economic evaluation, consid-
ering the 18-months follow-up period, will be costs,
quality of life and quality adjusted life years (QALYs).
The cost analysis exists of three main parts.
First, on patient level, volumes of care will be mea-
sured prospectively using TiC-P (part I), administrative
data. Cost items included are: number of outpatient
contacts, home visits, number and length of hospitaliza-
tions, but also ER/casualty department-visits, ambulance
transportation, and justice department contacts. Prod-
uctivity losses for patients (sick leave) will be estimated
using TiC-P part II. The friction cost-method will be
applied following the Dutch guidelines for cost analyses
[43]. Also travel time to an outpatient clinic and related
costs patients make, will be considered. Second, the cost
analysis consists of determining the cost prices for each
volume of consumption in order to use these for multi-
plying the volumes registered for each participating
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used [44]. For units of care/resources where no guideline
or standard prices are available real cost prices will be
determined. Third, per arm (intervention and control)
total costs will be determined using activity based cost-
ing. The effect analysis adheres to the design of a
randomized controlled trial and measures at baseline,
and follow-ups at 6, 12 and 18 months. To measure the
quality of life of patients a validated so-called health-
related quality of life (HRQoL) instrument will be used,
the EuroQol-5D (EQ-5D) [45].
The incremental cost-effectiveness ratio’s (ICERs) ‘cost
per unit change on the MANSA’ and ‘cost per QALY
gained’ will be computed and uncertainty surrounding
these ICERs will be determined using the bootstrap or
Fieller method. Cost-effectiveness acceptability curves
will be derived that are able to evaluate efficiency by
using different thresholds (Willingness To Pay) for a unit
change on the MANSA and a QALY gained. The impact
of uncertainty surrounding deterministic parameters (for
example prices) on the ICER will be explored using one-
way sensitivity analyses on the range of extremes.
Discussion
No RCT, nor cost-effectiveness study, has been con-
ducted on Interpersonal Community Psychiatric Treat-
ment so far – only one, small pilot study, promising
better outcomes than in usual care. The empirical base
for current care as usual is small, if not absent. This
study will fill this void, and generate data that is needed
to inform and hopefully improve daily mental health
care. In summary, we assume that ICPT is more effective
in improving patients’ quality of life and social networks,
preventing or decreasing professionals’ perception of
patients as ‘difficult’, discharging patients to a lower
level of care and being less costly in reaching these
clinical goals than CAU. The patient group we focus on,
receives long term care and suffers from various non-
psychotic psychiatric diagnoses. The strength of ICPT is
its focus on this varied group of patients, for whom
current care is unsatisfactory.
The rationale performing a cluster-randomized design
is threefold. First: data from this trial will be clustered at
multiple levels, due to three participating institutions,
various departments within these institutions, and vari-
ous professionals (=cluster level) within these depart-
ments. Second: contamination of treatment methods is
likely when professionals treat patients in both the
experimental and control condition. Contamination is
less likely in the current design since participating pro-
fessionals have limited contact on treatments or
methods with one another outside official treatment
progress meetings – in which there is little time to dis-
cuss treatment content. Therefore randomization at thelevel of professionals is preferable. Third: refusal to be
randomized is likely with this patient group. Many
patients find it difficult to switch to another profes-
sional since they may have a long-term working alliance
with their present professional. Randomization there-
fore takes place on the professional level instead of on
patient level.
It is expected that this study will yield results that
may well be generalized across everyday mental health
care. Since our target population consists of patients
who are high care users, who are more willing to par-
ticipate than patients who receive for example assertive
outreach [9], we do not expect high selection bias.
There are a limited number of inclusion and exclusion
criteria in our trial. Unlike in many other trials, patients
who are suicidal, aggressive, or self-harming are wel-
come to participate. Also, comorbidity as well as
substance abuse are no exclusion criteria. To encourage
participation by professionals, a tailored training-
program was developed, based on their day-to-day
work with the participants involved. A limitation of this
study is the lack of blinding. Participating professionals
will know that they conduct ICPT instead of CAU.
Patients will also not be blinded.
Abbreviations
CANSAS: Camberwell Assessment of Need Short Appraisal Schedule;
CAU: care as usual; DALY: Disability-adjusted life years; DDPRQ: Difficult
Doctor Patient Relation Questionnaire; EQ-5D: Europol 5D; HONOS: Health
Nation Outcome Scale; ICER: incremental cost-effectiveness ratio;
ICPT: Interpersonal Community Psychiatric Treatment; IMR: Illness Management
and Recovery; MANSA: Manchester Short Assessment of Quality of Life;
MHS: Mental Health Services; MINI Plus: (Mini Neuro-psychiatric Interview);
OQ45: Outcome Questionnaire45; QUALY: quality adjusted life years;
SAPAS: Standardised Assessment of Personality –Abbreviated Scale, Self Report
-SIDP-IV, Structured Interview for DSM-IV; SNM: Social Network Map; STAR: Scale
to Assess the Therapeutic Relationship; Tic-P: Trimbos/iMTA questionnaire for
Costs associated with Psychiatric Illness.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MvV prepared the study, drafted this paper and will carry out the study. BK
developed and piloted the ICPT-treatment, designed the present study and
obtained funding for it. TvA, LS and NM supervised the project and co-applied
for funding. DP and EA designed the cost effectiveness component and drafted
this part of the manuscript. ST offered statistical and methodological advice. All
authors contributed to the design of the study and read and approved the final
manuscript.
Acknowledgements
This study is funded under the RAAK-scheme which is managed by the
Foundation Innovation Alliance (SIA; Stichting Innovatie Alliantie). Co-funding
is provided by the HAN University of Applied Sciences.
Author details
1Research Group Social Psychiatry & Mental Health Nursing, University of
Applied Sciences Arnhem Nijmegen, PO Box 6960, Nijmegen, GL 6503, The
Netherlands. 2Altrecht Mental Health Services, Oude Arnhemseweg 260,
Zeist, BK 3705, The Netherlands. 3Pro Persona Mental Health Services,
Wolfheze 2 ProCES, Renkum, BE 6874, The Netherlands. 4Department of
Psychiatry, Erasmus MC, University Medical Center, PO Box 2040, Rotterdam,
CA 3000, The Netherlands. 5Department of Research and Development, GGZ
van Veen et al. BMC Psychiatry  (2015) 15:100 Page 9 of 10Oost Brabant Mental Health Services, PO Box 3, Boekel, ZG 5427, The
Netherlands. 6Epidemiology, Biostatistics & Health Technology Assessment,
Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen,
GA 6525, The Netherlands. 7Scientific Institute for Quality of Healthcare,
Radboud University Medical Center Nursing science, PO Box 9101, Nijmegen,
HB 6500, The Netherlands. 8Faculty of Health Sciences Highfield,
Southampton, University of Southampton, SO17 1BJ Southampton, UK.
9Centre for Health Services and Nursing Research, Kapucijnenvoer 35 blok d,
box 70013000 Leuven, Belgium.
Received: 3 December 2014 Accepted: 23 April 2015
References
1. De Graaf R, Ten Have M, van Dorsselaer S. De psychische gezondheid van
de Nederlandse bevolking. NEMESIS-2 [The Netherlands Mental Health
Survey and Incidence Study-2]. Utrecht: Trimbos Instituut; 2010.
2. National Institute for Public Health and the Environment (RIVM). A healthier
Netherlands: Key findings from the Dutch 2014 Public Health Status and
Foresight Report. Bilthoven: National Institute for Public Health and the
Environment; 2014.
3. Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM-IV Personality
Disorders in the National Comorbidity Survey Replication (NCS-R). Biol Psych.
2007;62:553–64.
4. Nederland GGZ. Zorg op waarde geschat: update [Care valued: update].
Sectorrapport 2010. Amersfoort: GGZ NL; 2010.
5. Dieperink CJ, Pijl YJ, Mulder CL, van Os J, Drukker M. Langdurig
zorgafhankelijke patiënten in de ggz: samenhang met verstedelijking
[Long-term service-dependent patients in mental health care: connection to
urbanization], Tijdschrift voor Psychiatrie. 2008. p. 761–9.
6. Dieperink C, Pijl B, Driessen G. Langdurig zorgafhankelijken in de GGZ. Een
landelijke verkenning op basis van psychiatrische casusregisters [Long-term
service-dependent patients in mental health care. A rural exploration based
on psychiatric case registers]. Maandblad Geestelijke Volksgezondheid.
2006;61:228–38.
7. Koekkoek B, van Meijel B, Hutschemaekers G. Community mental healthcare
for people with severe personality disorder: narrative review. Psychiatrist.
2010;34:24–30.
8. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ.
A comparison of nefazodone, the cognitive behavioral-analysis system of
psychotherapy, and their combination for the treatment of chronic
depression. New Engl J Med. 2000;342((20):1462–70.
9. Koekkoek B, van Meijel B, Schene A, Smit A, Kaasenbrood A, Hutschemakers
G. Interpersonal community psychiatric treatment for non-psychotic chronic
patients and nurses in outpatient mental health care. Int J Nurs Stud.
2012;49(5):549–59.
10. Kent S, Fogarty M, Yellowlees P. Heavy utilization of inpatient and
outpatient services in a public mental health service. Psych Serv.
1995;46:1254–7.
11. Hahn SR, Kroenke K, Spitzer RL, Brody D, Williams JBW, Linzer M, et al. The
difficult patient: prevalence, psychopathology, and functional impairment.
J Gen Inter Med. 1996;11:1–8.
12. Koekkoek B, van Meijel B, Tiemens B, Schene A, Hutschemaekers G. What
makes community psychiatric nurses label non-psychotic chronic patients
as ‘difficult’? Soc Psychiatry Psychiatric Epidemiol. 2010;46:1045–53.
13. Podrasky DL, Sexton DL. Nurses’ reactions to difficult patients. Image J Nurs
Sch. 1988;20:16–21.
14. Jackson JL, Chamberlin J, Kroenke K. Predictors of patient satisfaction. Soc
Sci Med. 2001;52:609–20.
15. Koekkoek B, Hutschemaekers G, van Meijel B, Schene A. How do patients
come to be seen as ‘difficult’ ?: A mixed-methods study in community
mental health care. Soc Sci Med. 2011;72:504–12.
16. Koekkoek B, van Meijer B, Hutschemaekers G. Difficult patients’in mental
health care: a review. Psychiatr Serv. 2006;57:795–802.
17. Teerenstra S, Eldridge S, Graff M, de Hoop E, Borm GF. A simple sample size
formula for analysis of covariance in cluster randomized trials. Stat Med.
2012;31(20):2169–78.
18. Koekkoek B, van Meijel B, Schene A, Hutschemaekers G. Development of an
intervention program to increase effective behaviours by patient and
professionals in psychiatric services: intervention mapping study. Health
Serv Res. 2010;10:293.19. McCullough JP. Treatment for chronic depression. Cognitive behavioural
analysis system of psychotherapy. New York: Guilford Press; 2000.
20. Linehan MM. Cognitive-behavioral treatment of borderline personality
disorder. New York: Guilford Press; 1993.
21. Prochaska JO, DiClemente CC. Stages of change in the modification of
problem behaviors. Prog Behav Modif. 1992;28:183–218.
22. Phelan M, Slade M, Thornicroft G, Dunn G, Holloway F, Wykes T, et al. The
Camberwell assessment of need: the validity and reliability of an instrument
to assess the needs of people with severe mental illness. Br J Psychiatry.
1995;167(5):589–95.
23. Duncan BL, Miller SD, Sparks JA, Claud DA, Reynolds LR, Brown J, et al. The
session rating scale: preliminary psychometric properties of a “working”
alliance measure. J Brief Ther. 2003;3(1):3–12.
24. Rotteveel RJ, Vanmolkot LML. Het intervisieprotocol. Houvast bij de
hulpverlening aan chronische patiënten [The intervision protocol. Structure
in working with chronic patients]. Maandblad Geestelijke Volksgezondheid.
1993;48(12):1299–311 [10].
25. Koekkoek B. Steun vanaf een wankele basis [Providing support from shaky
ground]. Maandblad Geestelijke Volksgezondheid. 2004;59:214–26.
26. Hellenbrand I, Tiemens B, Appel T. Lange behandelingen ontberen scherpe
behandeldoelen [Long term treatments lack sharp treatment goals]. Psycho
Praxis. 2007;9:90–3.
27. Kaasenbrood A, Hanneman PJJ, van der Werf LJ. Hinderende hulpeisers.
Patiënten waar hulpverleners onder lijden en over ruziën [Ambivalent care
demanders. Patients mental health professionals suffer and argue about].
Maandblad Geestelijk Volksgezondheid. 2002;9:831–44.
28. Sheehan DV, Lecrubier Y, Sheehan KH, Janavs J, Weiller E, Keskiner A, et al.
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development
and validation of a structured diagnostic psychiatric interview for DSM-IV
and ICD-10. J Clin Psychiatry. 2002;59:22–3.
29. Germans S, Van Heck GL, Hodiamont PP. Results of the search for
personality disorder screening tools: clinical implications. J Clin Psychiatry.
2012;73(2):165–73.
30. Pfohl B, Blum N, Zimmerman M. The Structured Interview for DSM-IV
Personality Disorders (SIDP-IV). Iowa City: IA: University of Iowa College of
Medicine; 1995.
31. Priebe S, Huxley P, Knight S, Evans S. Application and results of the
Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psych.
1999;45:7–12.
32. Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ.
Measuring the quality of life in economic evaluations: the Dutch EQ-5D
tariff. Ned Tijdschr Geneeskd. 2005;149(28):1574–8.
33. Bebbington P, Brugha T, Hill T, Marsden L, Window S. Validation of the
health of the nation outcome scales. Br J Psychiatry. 1999;174:389–94.
34. Mulder CL, Staring ABP, Loos J, Buwalda V, Kuijpers D, Sytema S, et al. De
Health of the Nations Outcome Scales (HoNOS) als instrument voor ’routine
outcome assessment’. Tijdschr Psychiatr. 2004;46(5):273–85.
35. Lambert MJ, Burlingame GM, Umphress V, Hansen NB, Vermeersch DA,
Clouse GC, et al. The reliability and validity of the outcome questionnaire.
Clin Psychol Psychother. 1996;3:249–58.
36. De Jong K, Nugter MA, Polak MG, Wagenborg JEA, Spinhoven P, Heiser WJ.
De Nederlandse versie van de Outcome Questionnaire (OQ-45): a cross
cultural validation [De Nederlandse versie van de Outcome Questionnaire
(OQ-45): een cross culturele validatie]. Psychologie & Gezondheid.
2008;36(1):35–45.
37. Sklar M, Sarkin A, Gilmer T, Groessl E. The psychometric properties of the
illness management and recovery scale in a large american public mental
health system. Psychiatry Res. 2012;199(3):220–7. doi:10.1016/
j.psychres.2012.03.013. Epub 2012 Apr 12.
38. Hakkaart-van Rooijen L. Trimbos/iMTA questionnaire for costs associated
with psychiatric illness (TIC-P). Rotterdam: Erasmus University; 2002.
39. McGuire-Snieckus R, McCabe R, Catty J, Hansson L, Priebe S. A new scale to
assess the therapeutic relationship in community mental health care: star.
Psychol Med. 2007;37:85–95.
40. Hahn SR, Thompson KS, Wills TA, Stern V, Budner NS. The difficult
doctor-patient relationship: somatization, personality and psychopathology.
J Clin Epidemiol. 1994;47(6):647–57.
41. Tracy EM, Whittaker JK. The social network map. Fam Soc. 1990;71:461–70.
42. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL.
Methods for the Economic Evaluation of Health Care Programmes. 3rd ed.
Oxford (UK): Oxford University Press; 2005.
van Veen et al. BMC Psychiatry  (2015) 15:100 Page 10 of 1043. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Manual for research costs.
Methods and standard charges for economic evaluations in health care.
Diemen: College voor zorgverzekeringen; 2010.
44. Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullens CD, Nuijten M, et al.
Principles of good practice for budget impact analysis. Value Health.
2007;10:336–47.
45. Dolan P. Modeling valuations forEuroQol health states. Med Care.
1997;35:1095–108.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
